87 related articles for article (PubMed ID: 12592681)
21. Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine.
Wang XY; Zhang XX; Yao X; Jiang JH; Xie YH; Yuan ZH; Wen YM
Vaccine; 2010 Nov; 28(51):8169-74. PubMed ID: 20937312
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and experimental study on treatment of chronic hepatitis B with yanggan aoping mixture].
Yu RQ; Bi JJ; Wang QS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Mar; 17(3):155-8. PubMed ID: 9863082
[TBL] [Abstract][Full Text] [Related]
23. [Effect of bushen recipe on the immune effector molecules of natural killer cells in patients with chronic hepatitis B].
Gao YQ; Yao Y; Li M
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):710-3. PubMed ID: 20929127
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study on treatment of liver fibrosis in patients of hepatitis B by kangxian baogan decoction].
Liang TJ; Zhang W; Zhang CQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):332-4. PubMed ID: 12584827
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between the changes in immune cells and HBeAg loss following antiviral treatment in chronic hepatitis B patients].
Zheng Q; Zhu YY; Chen J; Liu YR; You J; Zeng DW; Lin S; Jiang JJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):801-6. PubMed ID: 23206296
[TBL] [Abstract][Full Text] [Related]
26. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of HBeAg positive chronic hepatitis B by xiaoyao powder combined with interferon-alpha: a clinical observation].
Liang HQ; Tang JM; Wu CC; Chen SD
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):666-70. PubMed ID: 25046946
[TBL] [Abstract][Full Text] [Related]
28. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
[TBL] [Abstract][Full Text] [Related]
29. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
Ling N; Zhou Z; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266
[TBL] [Abstract][Full Text] [Related]
30. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
Xie Y; Zhao H; Dai WS; Xu DZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
32. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].
Zhu M; Xu B; Yao GB
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894
[TBL] [Abstract][Full Text] [Related]
33. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
34. He Jie Tang in the treatment of chronic hepatitis B patients.
Chen ZX; Zhang SJ; Lao SX; Hu HT; Zhang CY; Guan SH; Gu YL
World J Gastroenterol; 2005 Nov; 11(42):6638-43. PubMed ID: 16425357
[TBL] [Abstract][Full Text] [Related]
35. [Effect of compound qizhu granule on cellular immunity of chronic hepatitis B patients].
Zhu YF; Gu XB; Guo XY; Yan ZH; Pu YC; Tu KW; Hua Z; Pei H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1178-81. PubMed ID: 25509258
[TBL] [Abstract][Full Text] [Related]
36. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
[TBL] [Abstract][Full Text] [Related]
37. High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.
Alexander G; Baba CS; Chetri K; Negi TS; Choudhuri G
BMC Gastroenterol; 2005 Sep; 5():29. PubMed ID: 16164746
[TBL] [Abstract][Full Text] [Related]
38. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between HBeAg seroconversion with genotypes and HBV specific CTL in patients with chronic hepatitis B treated with Adefovir dipivoxil].
Zhou YL; Wang XC; Wu YT; Tan YF; Zhao YP; Tang JM; Pan JQ; Yang ZX; Gu XB
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):220-3. PubMed ID: 21977598
[TBL] [Abstract][Full Text] [Related]
40. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
Hou J; Yin YK; Xu D; Tan D; Niu J; Zhou X; Wang Y; Zhu L; He Y; Ren H; Wan M; Chen C; Wu S; Chen Y; Xu J; Wang Q; Wei L; Chao G; Constance BF; Harb G; Brown NA; Jia J
Hepatology; 2008 Feb; 47(2):447-54. PubMed ID: 18080339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
